Cargando…
Integrated analysis of comprehensive metabolomics and network pharmacology to reveal the mechanisms of abelmoschus manihot (L.) medik. in the treatment of cisplatin-induced chronic kidney disease
Background: Abelmoschus manihot (L.) Medik (“Huangkui” in Chinese, HK) has been widely used for the treatment of kidney diseases. Nephrotoxicity is the side effect of cisplatin (CDDP), which greatly limits its clinical application. Therefore, CDDP could be used to establish the chronic kidney diseas...
Autores principales: | Liao, Jian-Cheng, Li, Chang-Yin, Teng, Feng-Meng, Jian-Chen, Yu, Jiang-Yi, Ju, Wen-Zheng, Zou, Jian-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715753/ https://www.ncbi.nlm.nih.gov/pubmed/36467079 http://dx.doi.org/10.3389/fphar.2022.1064498 |
Ejemplares similares
-
Integrated Network Pharmacology Analysis and Pharmacological Evaluation to Explore the Active Components and Mechanism of Abelmoschus manihot (L.) Medik. on Renal Fibrosis
por: Gu, Lifei, et al.
Publicado: (2020) -
The pharmacological mechanism of Abelmoschus manihot in the treatment of chronic kidney disease
por: Wei, Cuiting, et al.
Publicado: (2023) -
Traditional Uses, Chemical Constituents, Biological Properties, Clinical Settings, and Toxicities of Abelmoschus manihot L.: A Comprehensive Review
por: Luan, Fei, et al.
Publicado: (2020) -
Evaluation of the efficacy of Abelmoschus manihot (L.) on diabetic nephropathy by analyzing biomarkers in the glomeruli and proximal and distal convoluted tubules of the kidneys
por: Yu, Hongmei, et al.
Publicado: (2023) -
Chalcone Derivatives From Abelmoschus manihot Seeds Restrain NLRP3 Inflammasome Assembly by Inhibiting ASC Oligomerization
por: Su, Jinsong, et al.
Publicado: (2022)